Skip to Main Content

Paper Details

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients.
J Cancer
8
2017
Author NameAffiliation
Per-Henrik EdqvistUppsala University
Fredrik Pont??nUppsala University
Fredrik Pont??nUppsala University
  • 1 - 3

Datasets

Release 1.2